Eagle Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,129
| Closed | -$49.1K | – | 567 |
|
|
2023
Q3 | $49.1K | Hold |
13,129
| – | – | ﹤0.01% | 534 |
|
|
2023
Q2 | $56.1K | Buy |
+13,129
| New | +$56.1K | ﹤0.01% | 530 |
|
|
2022
Q2 | – | Sell |
-243,404
| Closed | -$3.14M | – | 569 |
|
|
2022
Q1 | $3.14M | Sell |
243,404
-121,931
| -33% | -$1.57M | 0.02% | 428 |
|
|
2021
Q4 | $6.12M | Sell |
365,335
-67,289
| -16% | -$1.13M | 0.03% | 382 |
|
|
2021
Q3 | $6.95M | Sell |
432,624
-63,917
| -13% | -$1.03M | 0.03% | 367 |
|
|
2021
Q2 | $6.87M | Buy |
496,541
+114,033
| +30% | +$1.58M | 0.03% | 386 |
|
|
2021
Q1 | $5.57M | Sell |
382,508
-14,212
| -4% | -$207K | 0.02% | 400 |
|
|
2020
Q4 | $6.89M | Sell |
396,720
-7,711
| -2% | -$134K | 0.04% | 341 |
|
|
2020
Q3 | $7.61M | Buy |
404,431
+6,631
| +2% | +$125K | 0.04% | 317 |
|
|
2020
Q2 | $6.89M | Buy |
+397,800
| New | +$6.89M | 0.04% | 332 |
|